JP2010530362A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010530362A5 JP2010530362A5 JP2010510239A JP2010510239A JP2010530362A5 JP 2010530362 A5 JP2010530362 A5 JP 2010530362A5 JP 2010510239 A JP2010510239 A JP 2010510239A JP 2010510239 A JP2010510239 A JP 2010510239A JP 2010530362 A5 JP2010530362 A5 JP 2010530362A5
- Authority
- JP
- Japan
- Prior art keywords
- hpv
- amino acid
- derived
- protein
- medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US94107007P | 2007-05-31 | 2007-05-31 | |
| EP07109287 | 2007-05-31 | ||
| PCT/NL2008/050315 WO2009002159A2 (en) | 2007-05-31 | 2008-05-27 | Intradermal hpv peptide vaccination |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014133168A Division JP5888823B2 (ja) | 2007-05-31 | 2014-06-27 | 皮内ｈｐｖペプチドワクチン接種 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010530362A JP2010530362A (ja) | 2010-09-09 |
| JP2010530362A5 true JP2010530362A5 (enExample) | 2011-06-30 |
Family
ID=38477016
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010510239A Pending JP2010530362A (ja) | 2007-05-31 | 2008-05-27 | 皮内ｈｐｖペプチドワクチン接種 |
| JP2014133168A Expired - Fee Related JP5888823B2 (ja) | 2007-05-31 | 2014-06-27 | 皮内ｈｐｖペプチドワクチン接種 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014133168A Expired - Fee Related JP5888823B2 (ja) | 2007-05-31 | 2014-06-27 | 皮内ｈｐｖペプチドワクチン接種 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US9562075B2 (enExample) |
| EP (1) | EP2155240B1 (enExample) |
| JP (2) | JP2010530362A (enExample) |
| CN (1) | CN101795705A (enExample) |
| AU (1) | AU2008269721B2 (enExample) |
| BR (1) | BRPI0812311A8 (enExample) |
| CA (1) | CA2688589A1 (enExample) |
| ES (1) | ES2482192T3 (enExample) |
| MX (1) | MX2009012922A (enExample) |
| WO (1) | WO2009002159A2 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2468763B1 (en) * | 2007-05-31 | 2014-06-18 | Academisch Ziekenhuis Leiden h.o.d.n. LUMC | HPV epitopes targeted by T cells infiltrating cervical malignancies for use in vaccines |
| JP5707326B2 (ja) * | 2008-09-02 | 2015-04-30 | アンティジェン・エクスプレス・インコーポレーテッドＡｎｔｉｇｅｎ Ｅｘｐｒｅｓｓ，Ｉｎｃ． | ヒトパピローマウイルス／Ｉｉ−ｋｅｙのハイブリッドおよびその使用方法 |
| JP6069212B2 (ja) | 2010-12-02 | 2017-02-01 | ビオノール イミュノ エーエスＢｉｏｎｏｒ Ｉｍｍｕｎｏ Ａｓ | ペプチド骨格設計 |
| EP2883550A1 (en) * | 2013-12-12 | 2015-06-17 | Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts | Novel promiscuous HPV16-derived T helper epitopes for immunotherapy |
| JP7092662B2 (ja) | 2015-10-30 | 2022-06-28 | チルドレンズ ナショナル メディカル センター | ナイーブｔ細胞集団からのｈｐｖ抗原特異的ｔ細胞の生成 |
| US11160861B2 (en) | 2015-11-18 | 2021-11-02 | Immunovaccine Technologies Inc. | Adjuvanting systems and water-free vaccine compositions comprising a polyI:C polynucleotide adjuvant and a lipid-based adjuvant |
| CN117018170A (zh) | 2016-06-20 | 2023-11-10 | Isa制药有限公司 | 肽疫苗制剂 |
| US11524063B2 (en) * | 2017-11-15 | 2022-12-13 | Arizona Board Of Regents On Behalf Of Arizona State University | Materials and methods relating to immunogenic epitopes from human papillomavirus |
| MA52003A (fr) * | 2018-03-12 | 2021-01-20 | Sqz Biotechnologies Co | Procédés de traitement de maladies associées au hpv |
| BR112020018612A2 (pt) * | 2018-03-12 | 2020-12-29 | Sqz Biotechnologies Company | Entrega intracelular de biomoléculas para modificar a resposta imune |
| EP3784688A2 (en) * | 2018-04-26 | 2021-03-03 | Agenus Inc. | Heat shock protein-binding peptide compositions and methods of use thereof |
| JP2024503277A (ja) * | 2020-12-29 | 2024-01-25 | スクイーズ バイオテクノロジーズ カンパニー | 活性化抗原担体の製剤 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4777239A (en) * | 1986-07-10 | 1988-10-11 | The Board Of Trustees Of The Leland Stanford Junior University | Diagnostic peptides of human papilloma virus |
| US5180806A (en) * | 1988-05-16 | 1993-01-19 | The Scripps Research Institute | Polypeptides and compositions of human papillomavirus latent proteins, diagnostic systems and methods |
| US5932412A (en) | 1990-05-11 | 1999-08-03 | Euro-Diagnostica Ab | Synthetic peptides in human papillomaviruses 1, 5, 6, 8, 11, 16, 18, 31, 33 and 56, useful in immunoassay for diagnostic purposes |
| DE9106105U1 (de) * | 1991-05-17 | 1991-11-07 | Behringwerke Ag, 3550 Marburg | Diagnose-Kit zum Nachweis von Human-Papillomavirusinfektionen |
| US6419931B1 (en) | 1991-08-26 | 2002-07-16 | Epimmune Inc. | Compositions and methods for eliciting CTL immunity |
| GB9505784D0 (en) * | 1995-03-22 | 1995-05-10 | Lynxvale Ltd | Anti-tumour treatment |
| WO1997023237A1 (en) | 1995-12-22 | 1997-07-03 | Immunomedics, Inc. | Use of immunoconjugates to enhance the efficacy of multi-stage cascade boosting vaccines |
| WO1999061065A1 (en) | 1998-05-23 | 1999-12-02 | Leiden University Medical Center | Cd40 binding molecules and ctl peptides for treating tumors |
| US20030118588A1 (en) | 1999-05-22 | 2003-06-26 | Linda Diehl | Induction of anti-tumor CTL immunity through in vivo triggering of 4-1BB and/or CD40 |
| US6641994B2 (en) * | 1999-08-25 | 2003-11-04 | Pharmacia & Upjohn Company | Methods of identifying anti-viral agents |
| US20020044948A1 (en) * | 2000-03-15 | 2002-04-18 | Samir Khleif | Methods and compositions for co-stimulation of immunological responses to peptide antigens |
| ES2724121T3 (es) * | 2000-12-08 | 2019-09-06 | Academisch Ziekenhuis Leiden | Péptidos largos de 22-45 residuos de aminoácidos que inducen y/o mejoran las respuestas inmunológicas específicas para antígenos |
| EP1417353A4 (en) * | 2001-07-20 | 2005-08-03 | Univ Texas | METHODS AND COMPOSITIONS ASSOCIATED WITH HPV ASSOCIATED PENCILS AND CANNULAR WELLS, INCLUDING CIN |
| US6884605B2 (en) * | 2001-08-09 | 2005-04-26 | Board Of Trustees Of The University Of Arkansas | Compositions, methods and products comprising human papillomavirus for detecting and treating a cancer |
| EP1708745B1 (en) | 2003-12-23 | 2012-04-18 | Arbor Vita Corporation | Antibodies for oncogenic strains of hpv and methods of their use |
| JP2007528838A (ja) * | 2003-12-24 | 2007-10-18 | ライデン ユニバーシティ メディカル センター | 腫瘍特異的ワクチンとしての合成タンパク質 |
| US8252893B2 (en) | 2005-01-31 | 2012-08-28 | Board Of Trustees Of The University Of Arkansas | CD8 T cell epitopes in HPV 16 E6 and E7 proteins and uses thereof |
| CN101189014A (zh) * | 2005-04-27 | 2008-05-28 | 莱顿大学医学中心 | 用于治疗hpv诱导的上皮内瘤样病变的方法和手段 |
| AR054822A1 (es) | 2005-07-07 | 2007-07-18 | Sanofi Pasteur | Emulsion inmuno adyuvante |
-
2008
- 2008-05-27 JP JP2010510239A patent/JP2010530362A/ja active Pending
- 2008-05-27 CN CN200880101172A patent/CN101795705A/zh active Pending
- 2008-05-27 WO PCT/NL2008/050315 patent/WO2009002159A2/en not_active Ceased
- 2008-05-27 ES ES08753797.3T patent/ES2482192T3/es active Active
- 2008-05-27 CA CA002688589A patent/CA2688589A1/en not_active Abandoned
- 2008-05-27 EP EP08753797.3A patent/EP2155240B1/en not_active Not-in-force
- 2008-05-27 AU AU2008269721A patent/AU2008269721B2/en not_active Ceased
- 2008-05-27 MX MX2009012922A patent/MX2009012922A/es active IP Right Grant
- 2008-05-27 US US12/451,983 patent/US9562075B2/en not_active Expired - Fee Related
- 2008-05-27 BR BRPI0812311A patent/BRPI0812311A8/pt not_active IP Right Cessation
-
2014
- 2014-06-27 JP JP2014133168A patent/JP5888823B2/ja not_active Expired - Fee Related
-
2016
- 2016-12-16 US US15/381,367 patent/US20170143818A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wu et al. | Improving therapeutic HPV peptide-based vaccine potency by enhancing CD4+ T help and dendritic cell activation | |
| Meyer et al. | Clinical investigations of Toll-like receptor agonists | |
| Lin et al. | Therapeutic hpv DNA vaccines | |
| CN101528255A (zh) | Hpv抗原融合蛋白疫苗组合物及其应用 | |
| JP5230891B2 (ja) | 抗原特異的ｔ細胞の新規な誘導方法 | |
| Zhang et al. | Effects of astragalus polysaccharide on the immune response to foot-and-mouth disease vaccine in mice | |
| WO2004003143A3 (en) | Viruses and virus-like particles for multiple antigen and target display | |
| WO2003090686A3 (en) | Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality | |
| JP2009541373A5 (enExample) | ||
| JP2026063187A (ja) | Ｉ型インターフェロン遺伝子を刺激するための方法及びカチオン性脂質を含む組成物 | |
| US10112978B2 (en) | Peptide and use thereof | |
| RU2011123700A (ru) | Нонапептид с противоопухолевой активностью | |
| JP2014508734A5 (enExample) | ||
| Chuang et al. | Treatment with imiquimod enhances antitumor immunity induced by therapeutic HPV DNA vaccination | |
| Tseng et al. | Treatment with proteasome inhibitor bortezomib enhances antigen-specific CD8+ T-cell-mediated antitumor immunity induced by DNA vaccination | |
| JP2010506926A5 (enExample) | ||
| US8470372B2 (en) | Material with immunogenicity | |
| Pokorná et al. | Vaccination with human papillomavirus type 16-derived peptides using a tattoo device | |
| Cho et al. | Advances in human papilloma virus vaccines: a patent review | |
| Peng et al. | Vascular disrupting agent DMXAA enhances the antitumor effects generated by therapeutic HPV DNA vaccines | |
| EP3072512B1 (en) | Use of new type of anti-hpv pharmaceutical preparation | |
| KR20180112043A (ko) | 백신을 사용하여 암 또는 피부 병변을 치료하기 위한 방법 및 조성물 | |
| CN105732780B (zh) | 一种枯草颖肽素及其应用 | |
| RU2006119462A (ru) | Применение специфических гистонов при лечении паразитарных заболеваний | |
| KR20080019569A (ko) | 인유두종 바이러스（ｈｐｖ）유전자를 포함하는자궁경부암의 치료 또는 예방용 ｄｎａ 백신 |